Evidence map›Paper›PMID 35792082›Full record

ArticleeLife2022

β2-subunit alternative splicing stabilizes Cav2.3 Ca

Anita Siller, Nadja T Hofer, Giulia Tomagra, Nicole Burkert, Simon Hess, Julia Benkert, Aisylu Gaifullina, Desiree Spaich, Johanna Duda, Christina Poetschke and 9 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Motor-to-Limbic Design of Direct Synaptic Communication between Dopamine Neurons in the Midbrain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 4 countries.

Anita SillerDepartment of Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.
Nadja T HoferDepartment of Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.
Giulia TomagraDepartment of Drug Science, NIS Centre, University of Torino, Torino, Italy.
Nicole BurkertInstitute of Applied Physiology, University of Ulm, Ulm, Germany, Ulm, Germany.
Simon HessInstitute for Zoology, Biocenter, University of Cologne, Cologne, Germany.
Julia BenkertInstitute of Applied Physiology, University of Ulm, Ulm, Germany, Ulm, Germany.
Aisylu GaifullinaInstitute of Applied Physiology, University of Ulm, Ulm, Germany, Ulm, Germany.
Desiree SpaichInstitute of Applied Physiology, University of Ulm, Ulm, Germany, Ulm, Germany.
Johanna DudaInstitute of Applied Physiology, University of Ulm, Ulm, Germany, Ulm, Germany.
Christina PoetschkeInstitute of Applied Physiology, University of Ulm, Ulm, Germany, Ulm, Germany.
Kristina VilusicDepartment of Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.
Eva Maria FritzDepartment of Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.
Toni SchneiderInstitute of Neurophysiology, University of Cologne, Cologne, Germany.
Peter KloppenburgInstitute for Zoology, Biocenter, University of Cologne, Cologne, Germany.ORCID 0000-0002-4554-404X
Birgit LissInstitute of Applied Physiology, University of Ulm, Ulm, Germany, Ulm, Germany.
Valentina CarabelliDepartment of Drug Science, NIS Centre, University of Torino, Torino, Italy.
Emilio CarboneDepartment of Drug Science, NIS Centre, University of Torino, Torino, Italy.ORCID 0000-0003-2239-6280
Nadine Jasmin OrtnerDepartment of Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.ORCID 0000-0003-3882-3283
Jörg StriessnigDepartment of Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-9406-7120
Universität Ulm · DEUniversität Innsbruck · ATUniversity of Cologne · DEUniversity of Turin · IT

Funding

Austrian Science Fund FWF DOC 30Austrian Science Fund FWF P 27809Austrian Science Fund FWF P 35722
6 · The paper itself

Abstract

In dopaminergic (DA)

Indexed as

Dopaminergic NeuronsParkinson DiseaseAlternative SplicingAnimalsMesencephalonMiceSubstantia Nigracalcium channel blockerscalcium channel modulationmousemouse brain slicesmouse midbrain dopamine neuronsneurosciencevoltage-gated calcium channels

Identifiers

PMID35792082
PMCPMC9307272
OpenAlexW4283834433

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.